Literature DB >> 15068227

Implementation of community consultation for waiver of informed consent in emergency research: one Institutional Review Board's experience.

Emily S Dix1, Domenic Esposito, Frances Spinosa, Nancy Olson, Stanley Chapman.   

Abstract

BACKGROUND: This article describes how one Institutional Review Board (IRB) chose to implement the issue of waiver of consent for a research study involving brain trauma victims brought to an emergency department.
METHODS: Presentations were conducted in the state of Mississippi among cultural and ethnic groups representative of Mississippi's demographic composition. Individuals from the neurotrauma research team, including neurosurgeons and nurse study coordinators, conducted all of the presentations. One IRB member served as an objective "community liaison" and attended all presentations. This individual administered evaluation forms to attendees that measured their levels of comprehension and acceptance for the use of waiver of consent in the brain trauma study.
RESULTS: All of the 137 attendees in 7 community consultation meetings gave their approval for the use of "waiver of consent." Continued community consultations are planned for the duration of the brain trauma study.
CONCLUSION: Based on our experience, we conclude that in collaborating with local IRBs, research teams can successfully develop strategies for obtaining "acceptable community consultations" as required by regulatory mandates. We suggest that standardized community consultation guidelines be developed for obtaining waivers of informed consent in emergency research. Such criteria should form the basis for local IRBs to obtain their respective community consultations.

Entities:  

Keywords:  Biomedical and Behavioral Research; Empirical Approach

Mesh:

Year:  2004        PMID: 15068227     DOI: 10.1136/jim-52-02-20

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  7 in total

1.  A community consultation survey to evaluate support for and success of the IMMEDIATE trial.

Authors:  Joni R Beshansky; Patricia R Sheehan; Kenneth J Klima; Nira Hadar; Ellen M Vickery; Harry P Selker
Journal:  Clin Trials       Date:  2014-04       Impact factor: 2.486

Review 2.  Ethical goals of community consultation in research.

Authors:  Neal Dickert; Jeremy Sugarman
Journal:  Am J Public Health       Date:  2005-06-16       Impact factor: 9.308

3.  A qualitative study of institutional review board members' experience reviewing research proposals using emergency exception from informed consent.

Authors:  Katie B McClure; Nicole M Delorio; Terri A Schmidt; Gary Chiodo; Paul Gorman
Journal:  J Med Ethics       Date:  2007-05       Impact factor: 2.903

4.  The random dialing survey as a tool for community consultation for research involving the emergency medicine exception from informed consent.

Authors:  Eileen M Bulger; Terri A Schmidt; Andrea J Cook; Karen J Brasel; Denise E Griffiths; Peter J Kudenchuk; Daniel Davis; Berit Bardarson; Ahamed H Idris; Tom P Aufderheide
Journal:  Ann Emerg Med       Date:  2008-09-27       Impact factor: 5.721

5.  Perceived challenges to obtaining informed consent for a time-sensitive emergency department study of pediatric status epilepticus: results of two focus groups.

Authors:  James M Chamberlain; Kathleen Lillis; Cheryl Vance; Kathleen M Brown; Olubunmi Fawumi; Shari Nichols; Colleen O Davis; Tasmeen Singh; Jill M Baren
Journal:  Acad Emerg Med       Date:  2009-08       Impact factor: 3.451

Review 6.  Meeting unique requirements: Community consultation and public disclosure for research in emergency setting using exception from informed consent.

Authors:  Neal W Dickert; Kathleen Metz; Michael D Fetters; Adrianne N Haggins; Deneil K Harney; Candace D Speight; Robert Silbergleit
Journal:  Acad Emerg Med       Date:  2021-05-26       Impact factor: 5.221

Review 7.  Ethical principles--emergency medicine.

Authors:  Kenneth V Iserson
Journal:  Emerg Med Clin North Am       Date:  2006-08       Impact factor: 2.264

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.